tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
LEXX
Lexaria Bioscience
RESEARCH TOOLSreports

Lexaria Bioscience (LEXX) Stock News & Sentiment

Compare
239 Followers
Lexaria Bioscience Shareholders Endorse Directors and Auditors
Premium
Company Announcements
Lexaria Bioscience Shareholders Endorse Directors and Auditors
2d ago
8K
LEXX
Lexaria Adds Six Global Patents, Reaches 60 Granted as It Rallies Shareholders Ahead of 2026 Meeting
Premium
Company Announcements
Lexaria Adds Six Global Patents, Reaches 60 Granted as It Rallies Shareholders Ahead of 2026 Meeting
8d ago
LEXX
Lexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital
Premium
Company Announcements
Lexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital
18d ago
LEXX
Lexaria’s Phase 1b GLP-1 Study Shows Comparable Metabolic Outcomes and Encouraging Blood Pressure Data for DehydraTECH Platform
Premium
Company Announcements
Lexaria’s Phase 1b GLP-1 Study Shows Comparable Metabolic Outcomes and Encouraging Blood Pressure Data for DehydraTECH Platform
1M ago
LEXX
Lexaria’s DehydraTECH-Semaglutide Cuts GLP-1 Side Effects in Phase 1b Trial and Extends Cash Runway Into 2026
Premium
Company Announcements
Lexaria’s DehydraTECH-Semaglutide Cuts GLP-1 Side Effects in Phase 1b Trial and Extends Cash Runway Into 2026
1M ago
LEXX
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D
Premium
Company Announcements
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D
2M ago
LEXX
Lexaria Extends Agreement to Advance Drug Delivery Technology Evaluation
Premium
Company Announcements
Lexaria Extends Agreement to Advance Drug Delivery Technology Evaluation
3M ago
LEXX
More LEXX News >

LEXX News on the Web

Lexaria Bioscience Shareholders Endorse Directors and Auditors
TipRanks News
Neutral
Lexaria Adds Six Global Patents, Reaches 60 Granted as It Rallies Shareholders Ahead of 2026 Meeting
TipRanks News
Bullish
Lexaria Bioscience awarded six additional patents
TipRanks News
Bullish
Lexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital
TipRanks News
Bullish
Lexaria CEO says ‘closer to a commercial breakthrough than ever before’
TipRanks News
Bullish
Lexaria’s DehydraTECH-Semaglutide Cuts GLP-1 Side Effects in Phase 1b Trial and Extends Cash Runway Into 2026
TipRanks News
Neutral
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D
TipRanks News
Neutral
Mixed Catalysts Drive After-Hours Moves In MRM, LEXX, SHOT, AQST, And OVID
rttnews
Neutral

News Score - Last 7 Days

Neutral
LEXX
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average74%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LEXX’s Media Buzz Sentiment?
1 articles about LEXX were published this week. In an average week, 1.25 articles are published.
    What is LEXX’s weekly average amount of articles?
    In an average week, 1.25 articles about LEXX are published.
      What is LEXX’s News Sentiment?
      50% of articles about LEXX were positive this week, compared to its sector average of 74%.
        Healthcare Stocks that are Trending in the News
        IMAImageneBio
        HOCPFHOYA
        CBLControl Bionics Ltd.
        CRDFCardiff Oncology
        QNCXQuince Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week